MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2024.07.015

Медицинская библиотека · American heart journal · 2024

Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study).

Burgos Lucrecia María, Baro Vila Rocio Consuelo, Ballari Franco Nicolás, Goyeneche Ailin, Costabel Juan Pablo, Muñoz Florencia, Spaccavento Ana, Fasan Martín Andrés, Suárez Lucas Leonardo, Vivas Martin, Riznyk Laura, Ghibaudo Sebastian, Trivi Marcelo, Ronderos Ricardo, Botto Fernando, Diez Mirta, CAVAL US—AHF group

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The optimal assessment of systemic and lung decongestion during acute heart failure is not clearly defined. We evaluated whether inferior vena cava (IVC) and pulmonary ultrasound (CAVAL US) guided therapy is superior to standard care in reducing subclinical congestion at discharge in patients with AHF.

METHODS

CAVAL US-AHF was an investigator-initiated, single-center, single-blind, randomized controlled trial. A daily quantitative ultrasound protocol using the 8-zone method was used and treatment was adjusted according to an algorithm. The primary endpoint was the presence of more than 5 B-lines and/or an increase in IVC diameter and collapsibility at discharge. And secondary endpoint exploratory outcome was the composite of readmission for HF, unplanned visit for worsening HF or death at 90 days

RESULTS

Sixty patients were randomized to CAVAL US (n = 30) or control (n = 30). The primary endpoint was achieved in 4 patients (13.3%) in the CAVAL US group and 20 patients (66.6%) in the control group (P < .001). A significant reduction in HF readmission, unplanned visit for worsening HF or death at 90 days was seen in the CAVAL US group (13.3% vs 36.7%; log rank P = .038). Other endpoints such as NT-proBNP reduction at discharge showed a nonstatistically significant reduction in the CAVAL US group (48% IQR 27-67 vs 37% -3-59; P = .09). Safety outcomes were similar in both groups.

CONCLUSION

IVC and lung ultrasound-guided therapy in AHF patients significantly reduced subclinical congestion at discharge. CAVAL US-AHF provides preliminary evidence for the potential use of a simple technique to guide decongestive therapy during hospitalization for AHF, which may reduce the composite outcome at 90 days.

Для цитирования: Burgos Lucrecia María, Baro Vila Rocio Consuelo, Ballari Franco Nicolás, Goyeneche Ailin, Costabel Juan Pablo, Muñoz Florencia, Spaccavento Ana, Fasan Martín Andrés, Suárez Lucas Leonardo, Vivas Martin, Riznyk Laura, Ghibaudo Sebastian, Trivi Marcelo, Ronderos Ricardo, Botto Fernando, Diez Mirta, CAVAL US—AHF group. Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study).. American heart journal. 2024. DOI: 10.1016/j.ahj.2024.07.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.